Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty

• Status: Recruiting
• Trial end date: 2023-04-30
• Target enrollment: 0
• Participant gender: All

Summary

The investigators are evaluating the postoperative outcomes in patients undergoing total knee arthroplasty that receive either systemic lidocaine or ultrasound-guided adductor canal block as part of their anesthetic plan.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rhode Island Hospital
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• ASA PS 1-3 patients undergoing primary, unilateral total knee arthroplasty

Exclusion Criteria:

• ASA PS classification of 4 or greater

• Pre-existing neuropathy

• Coagulopathy

• Chronic opioid consumption (>3 months)

• Infection at the site

• Known allergy to study medications (lidocaine)

• High grade atrioventricular block (cardiac conduction system impairment)

• A history of CVA/TIA

• Currently using lidocaine patches

• Known liver disease